BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20577872)

  • 41. Vertebral morphometry by dual-energy X-ray absorptiometry (DXA) for osteoporotic vertebral fractures assessment (VFA).
    Diacinti D; Guglielmi G; Pisani D; Diacinti D; Argirò R; Serafini C; Romagnoli E; Minisola S; Catalano C; David V
    Radiol Med; 2012 Dec; 117(8):1374-85. PubMed ID: 22744340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opportunistic screening for osteoporosis using thoraco-abdomino-pelvic CT-scan assessing the vertebral density in rheumatoid arthritis patients.
    Perrier-Cornet J; Omorou AY; Fauny M; Loeuille D; Chary-Valckenaere I
    Osteoporos Int; 2019 Jun; 30(6):1215-1222. PubMed ID: 30868182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BFH-OST, a new predictive screening tool for identifying osteoporosis in postmenopausal Han Chinese women.
    Ma Z; Yang Y; Lin J; Zhang X; Meng Q; Wang B; Fei Q
    Clin Interv Aging; 2016; 11():1051-9. PubMed ID: 27536085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of low bone mass and prediction of fracture risk using metacarpal radiogrammetry method: a comparative study with DXA and X-ray phantom.
    Ashok Kumar D; Anburajan M; Snekhalatha U
    Int J Rheum Dis; 2018 Jul; 21(7):1350-1371. PubMed ID: 29968333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone mineral density referral for dual-energy X-ray absorptiometry using quantitative ultrasound as a prescreening tool in postmenopausal women from the general population: a cost-effectiveness analysis.
    Marín F; López-Bastida J; Díez-Pérez A; Sacristán JA;
    Calcif Tissue Int; 2004 Mar; 74(3):277-83. PubMed ID: 14708042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck.
    Di Paola M; Gatti D; Viapiana O; Cianferotti L; Cavalli L; Caffarelli C; Conversano F; Quarta E; Pisani P; Girasole G; Giusti A; Manfredini M; Arioli G; Matucci-Cerinic M; Bianchi G; Nuti R; Gonnelli S; Brandi ML; Muratore M; Rossini M
    Osteoporos Int; 2019 Feb; 30(2):391-402. PubMed ID: 30178159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validity of self-reported osteoporosis in mid-age and older women.
    Peeters GM; Tett SE; Dobson AJ; Mishra GD
    Osteoporos Int; 2013 Mar; 24(3):917-27. PubMed ID: 22673826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study.
    Silverman SL; Siris E; Belazi D; Recknor C; Papaioannou A; Brown JP; Gold DT; Lewiecki EM; Quinn G; Balasubramanian A; Yue S; Stolshek B; Kendler DL
    Arch Osteoporos; 2018 Aug; 13(1):85. PubMed ID: 30088189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women.
    Nayak S; Roberts MS; Greenspan SL
    Ann Intern Med; 2011 Dec; 155(11):751-61. PubMed ID: 22147714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Underuse and Overuse of Osteoporosis Screening in a Regional Health System: a Retrospective Cohort Study.
    Amarnath AL; Franks P; Robbins JA; Xing G; Fenton JJ
    J Gen Intern Med; 2015 Dec; 30(12):1733-40. PubMed ID: 25986135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline.
    Liu H; Paige NM; Goldzweig CL; Wong E; Zhou A; Suttorp MJ; Munjas B; Orwoll E; Shekelle P
    Ann Intern Med; 2008 May; 148(9):685-701. PubMed ID: 18458282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.
    Rubin KH; Rothmann MJ; Holmberg T; Høiberg M; Möller S; Barkmann R; Glüer CC; Hermann AP; Bech M; Gram J; Brixen K
    Osteoporos Int; 2018 Mar; 29(3):567-578. PubMed ID: 29218381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women.
    Mueller D; Gandjour A
    Value Health; 2009; 12(8):1106-17. PubMed ID: 19706151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Osteoporosis and Hip Fracture Risk From Routine Computed Tomography Scans: The Fracture, Osteoporosis, and CT Utilization Study (FOCUS).
    Adams AL; Fischer H; Kopperdahl DL; Lee DC; Black DM; Bouxsein ML; Fatemi S; Khosla S; Orwoll ES; Siris ES; Keaveny TM
    J Bone Miner Res; 2018 Jul; 33(7):1291-1301. PubMed ID: 29665068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification.
    Grampp S; Genant HK; Mathur A; Lang P; Jergas M; Takada M; Glüer CC; Lu Y; Chavez M
    J Bone Miner Res; 1997 May; 12(5):697-711. PubMed ID: 9144335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-energy distal radius fractures in middle-aged and elderly men and women--the burden of osteoporosis and fracture risk : A study of 1794 consecutive patients.
    Øyen J; Gjesdal CG; Brudvik C; Hove LM; Apalset EM; Gulseth HC; Haugeberg G
    Osteoporos Int; 2010 Jul; 21(7):1257-67. PubMed ID: 19813045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized trial of a mailed intervention and self-scheduling to improve osteoporosis screening in postmenopausal women.
    Warriner AH; Outman RC; Kitchin E; Chen L; Morgan S; Saag KG; Curtis JR
    J Bone Miner Res; 2012 Dec; 27(12):2603-10. PubMed ID: 22836812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Device-specific thresholds to diagnose osteoporosis at the proximal femur: an approach to interpreting peripheral bone measurements in clinical practice.
    Clowes JA; Peel NF; Eastell R
    Osteoporos Int; 2006; 17(9):1293-302. PubMed ID: 16810454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone mass.
    Zhang J; Delzell E; Curtis JR; Hooven F; Gehlbach SH; Anderson FA; Saag KG
    Osteoporos Int; 2014 Jan; 25(1):317-24. PubMed ID: 23982799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.